WO1990013314A3 - Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 (antigenes presentant avec eux une parente immunologique) - Google Patents

Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 (antigenes presentant avec eux une parente immunologique) Download PDF

Info

Publication number
WO1990013314A3
WO1990013314A3 PCT/FR1990/000336 FR9000336W WO9013314A3 WO 1990013314 A3 WO1990013314 A3 WO 1990013314A3 FR 9000336 W FR9000336 W FR 9000336W WO 9013314 A3 WO9013314 A3 WO 9013314A3
Authority
WO
WIPO (PCT)
Prior art keywords
glycoprotein
type
hiv
antigenes
transmembrane glycoprotein
Prior art date
Application number
PCT/FR1990/000336
Other languages
English (en)
Other versions
WO1990013314A2 (fr
Inventor
Ara Hovanessian
Maire-Anne Rey
Anne Laurent
Bernard Krust
Luc Montagnier
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8906322A external-priority patent/FR2646854A1/fr
Priority claimed from US07/356,459 external-priority patent/US5208321A/en
Application filed by Pasteur Institut filed Critical Pasteur Institut
Priority to EP90908240A priority Critical patent/EP0424519B1/fr
Priority to CA002032505A priority patent/CA2032505C/fr
Priority to DE69026569T priority patent/DE69026569T2/de
Publication of WO1990013314A2 publication Critical patent/WO1990013314A2/fr
Publication of WO1990013314A3 publication Critical patent/WO1990013314A3/fr
Priority to HK219796A priority patent/HK219796A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne une glycoprotéine antigénique gp80 caractérisée par les propriétés suivantes: elle a un poids moléculaire (PM) voisin de 80 kDa, elle est reconnue par des anticorps polyclonaux dirigés contre la glycoprotéine gp300, elle comprend en association sous forme d'un dimère, deux entités de la glycoprotéine transmembranaire d'enveloppe gp36, codée par le génome d'un rétrovirus humain du type HIV-2, susceptible de provoquer un SLA ou un SIDA chez l'homme , ou toute glycoprotéine de poids moléculaire du même ordre de grandeur, capable de former un complexe immunologique du type antigène-anticorps, avec des anticorps dirigés contre ladite gp80. L'invention vise également des anticorps dirigés contre cette glycoprotéine. Elle concerne aussi son application au diagnostic et à la vaccination.
PCT/FR1990/000336 1989-05-12 1990-05-11 Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 (antigenes presentant avec eux une parente immunologique) WO1990013314A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP90908240A EP0424519B1 (fr) 1989-05-12 1990-05-11 Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 (antigenes presentant avec eux une parente immunologique)
CA002032505A CA2032505C (fr) 1989-05-12 1990-05-11 Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 antigenes presentant avec eux une parente immunologique
DE69026569T DE69026569T2 (de) 1989-05-12 1990-05-11 Antigene eines transmembranen hüllenglycoproteins eines menschlichen retrovirus des typs hiv-2 und immunologisch verwandte antigene
HK219796A HK219796A (en) 1989-05-12 1996-12-24 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the HIV-2 type and antigens presenting with them an immunological relationship

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US356,459 1983-02-23
FR89/06322 1989-05-12
FR8906322A FR2646854A1 (fr) 1989-05-12 1989-05-12 Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 antigenes presentant avec eux une parente immunologique
US07/356,459 US5208321A (en) 1988-06-09 1989-05-25 HIV-2 transmembrane glycoprotein homodimer (GP 80)

Publications (2)

Publication Number Publication Date
WO1990013314A2 WO1990013314A2 (fr) 1990-11-15
WO1990013314A3 true WO1990013314A3 (fr) 1990-12-27

Family

ID=26227325

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1990/000336 WO1990013314A2 (fr) 1989-05-12 1990-05-11 Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 (antigenes presentant avec eux une parente immunologique)

Country Status (11)

Country Link
EP (1) EP0424519B1 (fr)
JP (5) JP3534746B2 (fr)
AT (1) ATE136789T1 (fr)
CA (1) CA2032505C (fr)
DE (1) DE69026569T2 (fr)
DK (1) DK0424519T3 (fr)
ES (1) ES2085908T3 (fr)
HK (1) HK219796A (fr)
OA (1) OA09634A (fr)
SG (1) SG48125A1 (fr)
WO (1) WO1990013314A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256561A (en) * 1991-12-20 1993-10-26 Abbott Laboratories Monoclonal antibody to HIV-2 and uses thereof
FR2692898B1 (fr) * 1992-06-30 1995-06-02 Centre Nat Rech Scient Procédé d'obtention de protéines membranaires, et utilisation de ces protéines dans un but de diagnostic ou de vaccination.
JP2013040148A (ja) * 2011-08-19 2013-02-28 Asahi Kasei Corp シアリルオリゴ糖ペプチド固定化ビーズ

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0269520A2 (fr) * 1986-11-21 1988-06-01 Institut Pasteur Rétrovirus du type HIV-2 susceptible de provoquer le sida, et ses constituants antigéniques et nucléiques
EP0283327A2 (fr) * 1987-01-16 1988-09-21 Institut Pasteur Peptides ayant des propriétés immunologiques de HIV-2
EP0314534A1 (fr) * 1987-09-07 1989-05-03 Transgene S.A. Vecteur d'expression des protéines du virus HIV-2, un des agents causal du SIDA
EP0320495A1 (fr) * 1986-01-22 1989-06-14 Institut Pasteur Retrovirus du type HIV-2 susceptible de provoquer le sida, et ses constituants antigéniques et nucléiques

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0320495A1 (fr) * 1986-01-22 1989-06-14 Institut Pasteur Retrovirus du type HIV-2 susceptible de provoquer le sida, et ses constituants antigéniques et nucléiques
EP0269520A2 (fr) * 1986-11-21 1988-06-01 Institut Pasteur Rétrovirus du type HIV-2 susceptible de provoquer le sida, et ses constituants antigéniques et nucléiques
EP0283327A2 (fr) * 1987-01-16 1988-09-21 Institut Pasteur Peptides ayant des propriétés immunologiques de HIV-2
EP0314534A1 (fr) * 1987-09-07 1989-05-03 Transgene S.A. Vecteur d'expression des protéines du virus HIV-2, un des agents causal du SIDA

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, Volume 111, 1989, M.A. REY et al.: "On the Processing of HIV-2 Envelope Glycoproteins", voir page 364* Resume 150196t & Res. Virol. 1989, 140(3), 271-4 (Eng)* *

Also Published As

Publication number Publication date
OA09634A (fr) 1993-04-30
ATE136789T1 (de) 1996-05-15
EP0424519B1 (fr) 1996-04-17
JP3534746B2 (ja) 2004-06-07
JP4423374B2 (ja) 2010-03-03
SG48125A1 (en) 1998-04-17
JP2003146999A (ja) 2003-05-21
JP2008156350A (ja) 2008-07-10
CA2032505C (fr) 2001-07-10
EP0424519A1 (fr) 1991-05-02
ES2085908T3 (es) 1996-06-16
JPH03506042A (ja) 1991-12-26
JP4174591B2 (ja) 2008-11-05
JP2005170949A (ja) 2005-06-30
DK0424519T3 (da) 1996-05-13
WO1990013314A2 (fr) 1990-11-15
JP2006213702A (ja) 2006-08-17
HK219796A (en) 1997-01-03
JP3833681B2 (ja) 2006-10-18
CA2032505A1 (fr) 1990-11-13
DE69026569T2 (de) 1996-09-05
DE69026569D1 (de) 1996-05-23

Similar Documents

Publication Publication Date Title
ATE64601T1 (de) Lymphadenopathie-assoziierte huellenantigene und deren verwendungen.
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
EP1630229A3 (fr) Antigènes du melanome
AU1225088A (en) Peptides having immunological properties 2-hiv-2
NZ219113A (en) Hiv peptide containing epitope of the env protein
EP2311952A3 (fr) Anticorps dirigé vers MART-1 protéine et ses fragments
CA2111325A1 (fr) Detection des virus de l'immunodeficience des mammiferes
FI931393A (fi) Peptider foer anvaendning vid vaccinering och induktion av neutraliserande motkroppar mot humant immunbristvirus
WO1990013314A3 (fr) Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 (antigenes presentant avec eux une parente immunologique)
AU8010791A (en) Hiv monoclonal antibody
WO1989009227A3 (fr) Peptides pf10 a pf19 d'un retrovirus hiv - procede de synthese de ces peptides - leur utilisation notamment pour le diagnostic
EP0250128A3 (fr) Virus isolé de patients atteints du SIDA
CA2160696A1 (fr) Peptides utiles pour la vaccination et l'induction d'anticorps neutralisateurs contre le virus de l'immunodefience humaine
HK167295A (en) Precursors of the HIV-2 retrovirus envelope glycoprotein and related antigens
ES2083388T3 (es) Anticuerpos dirigidos contra proteinas y glucoproteinas del retrovirus vih-2 eho - aplicaciones para el diagnostico.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BF BJ CF CG CH CM DE DK ES FR GA GB IT LU ML MR NL SE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1990908240

Country of ref document: EP

AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE BF BJ CF CG CH CM DE DK ES FR GA GB IT LU ML MR NL SE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2032505

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 1990908240

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1990908240

Country of ref document: EP